Showing results 2 to 2 of 2
The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma Park, Hye Jeong; Bae, Jun Sang; Kim, Kyoung Min; Moon, Young Jae; Park, See-Hyoung; Ha, Sang Hoon; Hussein, Usama Khamis; et al, JOURNAL OF EXPERIMENTAL CLINICAL CANCER RESEARCH, v.37, 2018-05 |
Discover